Fogorvosi szemle, 2008 (101. évfolyam, 1-6. szám)

2008-06-01 / 3. szám

FOGORVOSI SZEMLE

101. évf. 3. sz. 2008.

97

Irodalom

1. Abraham SN, Jonsson AB & Normark S: Fimbriae-mediated host pathogen cross-talk. Current Opinions in Microbiology 1998; 1: 75-81.

2. Allison, DG: The biofilm matrix. Biofouling 2003; 19: 139-150.

3. Anwar H & Costerton JW: Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1990; 34: 1666-1671.

4. Binder TA, Goodson JM & Socransky SS: Gingival fluid levels of acid and alkaline phosphatase. J Periodont Res 1987; 22: 14-19.

5. Boles BR, Thoendel M & Singh PK: Self-generated diversity produces “insurance effects’’ in biofilm communities. Proceedings of the National Academy of Science USA 2004; 101:16630-16635.

6. Bolstad AI, Jensen HB, Bakken V: Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev 1996; 9: 55-71.

7. Branda, SS, Vik, S, Friedman, L & Kolter, R: Biofilms: the matrix revisited. Trends in Microbiology 2005; 13: 20-26.

8. Briner WW, Grossman E, Buckner RY, Rebitski GF, et al: Effect of chlorhexidine gluconate mouthrinse on plaque bacteria. J Periodont Res 1986; 21:44-52.

9. Brinig MM, Lepp PW, Ouverney CC, Armitage GC & Relman DA: Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease. Applied and Environmental Microbiology 2003\ 69: 1687-1694.

10. Brook I: Direct and indirect pathogenicity of beta-lactamase-producing bacteria in mixed infections in children. Critical Reviews in Microbiology 1989; 16: 161-180.

11. Caldwell DE, Wolfaardt GM, Korber DR & Lawrence JR: Do bacterial communities transcend Darwinism? In: Jones, JG (ed.): Advances in Microbial Ecology, Vol. 15, pp. 105-191. New York, Plenum. (1997)

12. Carranza F & Shklar G: History of Periodontology. Quintessence Books, 2003. 52-52; 121-122 o.

13. Charles CH, Mostler KM, Bartles LL, Mankodi SM: Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6 month clinical trial. J Clin Periodontol 2004; 31: 878-884.

14. Costerton JW, Cheng KJ, Geesey GG, Ladd Tl, Nickel JC et al: Bacterial biofilms in nature and disease. Annual Rev of Microbiology 1987; 41: 435-464.

15. Dowson CG, Hutchison A, Woodford N, Johnson AP et al: Penicillin-resistant viridans streptococci have obtained altered penicillinbinding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proceedings of the National Academy of Science USA 1990; 87: 5858-5862.

16. Depaola LG, Overholster CD, Meiller TF, Minah GE, Niehaus C: Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development. J. Clin Periodontol 1989; 16: 311-315.

17. Faure E, Equils O, Sieling Pa, Thomas L et al: Bacterial lipopolysaccharide activates NF-kappa through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expresszion of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000; 275: 11058-11063.

18. Fine DH, Furgang D, üeb R, Korik I et al: Effects of sublethal exposure to an antiseptic mouthrinse on representative plaque bacteria. J Clin Periodontol 1996; 23: 444- 451.

19. Fine DH, Furgang D & Barnett ML: Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planktonic and biofilm forms of Actinobacillus actinomycetemcomitans. J Clin Periodontol 2001 ; 28: 697-700.

20. Fine DH: Mouthrinses as adjuncts for plaque and gingivitis management. A status report for the American Journal of Dentistry. Amer J Dentistry 1988; 1: 259-263.

21. Genco RJ: Host responses in periodontal diseases: current concepts. J Periodontol 1992; 63: 338-355.

22. Gera I (szerk.): Parodontológia. Semmelweis Kiadó, 2005. 67-93. o.

23. Gilbert P, Das J & Foley I: Biofilm susceptibility to antimicrobials. Advances in Dental Research 1997; 11:160-167.

24. Gilbert P, Maira-Litran T, Mcbain AJ, Rickard AH & Whyte FW: The physiology and collective recalcitrance of microbial biofilm communities. Advances in Microbial Physiology 2002; 46: 203-255.

25. Gordon JM, Lamster IB, Sieger MC: Efficacy of Listerine antiseptic in inhibition of the development of plaque and gingivitis. J Clin Periodontolt990; 12: 697-704.

26. Grossman E, Meckel AH, Isaacs RL et al: A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics and sanguinarine on dental plaque and gingivitis. J Periodontol 1989; 60: 435-440.

27. Grossman E, Rijn G, Sturzenberger OP et al: Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. J Periodont Res 1986; (Suppl) 33-43.

28. Gunsolelly JC: A meta-analyis of six-month studies of antiplaque and antigingivitis agents. J Amer Dent Assoc 2006; 137: 1649- 1657.

29. Hajishengallis G, Sojar H, Genco RJ, Denardin E: Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol Invest 2004; 33: 157- 172.

30. Hakenbeck R, König A, Kern I, Van Der Linden M, Keck W, Billot- Klein D, Legrand R, Schoot B & Gutmann L: Acquisition of five high-/Wr penicillin-binding protein variants during transfer of high-level B-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriology 1998; 180: 1831-1840.

31. Han DC, Huang GT, Lin LM, Warner NA, Gim JS, Jewett A: Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge. Oral Microbiol Immunol 2003; 18: 350-358.

32. Han Yw, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, Genco RJ: Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 2000; 68: 3140-3146.

33. Han YW, Redline RW, LI M, Yin L, Hill GB, Mccormick TS: Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 2004: 72: 2272- 2279.

34. Henderson B , Wilson M: Commensal communism and the oral cavity. J Dent Res 1998; 77: 1674-1683.

35. Henderson B, Poole S, Wilson M: Microbial/host interactions in health and disease: who controls the cytokine network? Immunopharmacology 1996; 35: 1-21.

36. Holt SC, Ebersole JL: Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia', the ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005: 38: 72-122.

37. Hol C, Van Duke EEM, Verduin CM, Verhoef J & Van Dijk H: Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. Journal of Infectious Diseases 1994; 170:1613-1616.

38. Johnson SA, Goddard PA, Iliffe C, Timmins B, Rickard AH, Robson G & Handley PS: Comparative susceptibility of resident and transient hand bacteria to para-chloro-meta-xylenol and triclosan. J Applied Microbiology 2002;93: 336-344.

39. Kinniment SL, Wimpenny JWT, Adams D & Marsh PD: The effect of chlorhexidine on defined, mixed culture oral biofilms grown in a novel model system. J Applied Bacteriology 1996; 81:120-125.

40. Kolenbrander PE: Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 2000; 54: 413-437.

41. Kolenbrander PE, Andersen RN, Holdeman LV: Coaggregation of oral Bacteroides species with other bacteria: central role in coaggregation bridges and competitions. Infect Immun 1985; 48: 741- 746.

42. Kolenbrander PE, London J: Ecological significance of coaggregation among bacteria. Adv Microb Ecol 1992; 12: 183-217.

43. Krisanaprakornkit S, Kimball JR, Weinberg A et al: Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells. Multiple signaling pathways and role of commen-